Trial intelligence / Profile preview

Booster Dose of MenQuadfi in Adolescents and Adults

NCT04084769Phase 3Completed

Sponsor
Sanofi
Start
Sep 2019
Primary completion
Sep 2020
Modality
Vaccines & Immunotherapeutics
Countries
2
01

Overview

A Phase 3 trial of meningococcal A conjugate vaccine in meningococcal disease, sponsored by Sanofi. Started Sep 2019; status: completed.

02

Drugs

meningococcal A conjugate vaccine
03

Conditions

meningococcal disease

Beyond the preview

Go deeper on NCT04084769.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04084769.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call